Genital prolapse in women.
Prolapse of the uterus or vagina is usually the result of loss of pelvic muscle support, and causes mainly non-specific symptoms. It may affect over half of women aged 50-59 years, but spontaneous regression may occur. Risks of genital prolapse increase with advancing parity and age, increasing weight of the largest baby delivered, and hysterectomy. We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of non-surgical treatments in women with genital prolapse? What are the effects of surgical treatments in women with genital prolapse? We searched: Medline, Embase, The Cochrane Library and other important databases up to August 2006 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). We found four systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions. In this systematic review we present information relating to the effectiveness and safety of the following interventions: abdominal Burch colposuspension, abdominal sacral colpopexy, abdominal sacrohysteropexy, anterior colporrhaphy with mesh reinforcement, laparoscopic surgery, mesh or synthetic grafts, native (autologous) tissue, open abdominal surgery, pelvic floor muscle exercises, posterior colporrhaphy (with or without mesh reinforcement), posterior intravaginal slingplasty (infracoccygeal sacropexy), sacrospinous colpopexy (vaginal sacral colpopexy), sutures, traditional anterior colporrhaphy, transanal repair, ultralateral anterior colporrhaphy alone or with cadaveric fascia patch, vaginal hysterectomy, vaginal oestrogen, vaginal pessaries, and vaginal sacrospinous colpopexy.